The phenomenon of treatment failures in Human African Trypanosomiasis
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 6 (11) , 906-914
- https://doi.org/10.1046/j.1365-3156.2001.00775.x
Abstract
Treatment of Human African Trypanosomiasis (HAT or sleeping sickness) relies on a few drugs which are old, toxic and expensive. The most important drug for the treatment of second stage infection is ...Keywords
This publication has 24 references indexed in Scilit:
- Drug resistance in pathogenic African trypanosomes: what hopes for the future?Veterinary Parasitology, 2001
- Infection of organotypic slice cultures from rat central nervous tissue with Trypanosoma brucei bruceiInternational Journal of Medical Microbiology, 2000
- Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolizedTropical Medicine & International Health, 1998
- Susceptibility of severe combined immuno‐deficient (SCID) mice to Trypanosoma brucei gambiense and T. b. rhodesienseTropical Medicine & International Health, 1998
- Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprolTropical Medicine & International Health, 1997
- Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasitesActa Tropica, 1993
- Pharmacology of existing drugs for animal trypanosomiasisActa Tropica, 1993
- Arsenical-resistant trypanosomes lack an unusual adenosine transporterNature, 1993
- In vitro drug sensitivity test for Trypanosoma brucei subgroup bloodstream trypomastigotesActa Tropica, 1989